PARSIPPANY, N.J., May 01, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, today announced that management will participate in the following investor events:
2024 BofA Securities Healthcare Conference
2024 Jefferies Global Healthcare Conference
2024 Truist Securities MedTech Conference
- Management will host one-on-one investor meetings on Tuesday, June 18, 2024, at the InterContinental Hotel in Boston.
2024 Stifel’s Inaugural ADA Diabetes Tech Summit
- Management will host a fireside session on Friday, June 21, 2024, in Orlando.
About embecta
embecta is one of the largest pure-play diabetes care companies in the world, leveraging its nearly 100-year legacy in insulin delivery to empower people with diabetes to live their best life through innovative solutions, partnerships and the passion of approximately 2,000 employees around the globe. For more information, visit embecta.com or follow our social channels on LinkedIn, Facebook, Instagram and Twitter.
Contacts:
| Media | Investors |
| Christian Glazar | Pravesh Khandelwal |
| Sr. Director, Corporate Communications | VP, Head of Investor Relations |
| 908-821-6922 | 551-264-6547 |
| Contact Media Relations | Contact IR |
